Biotech Holders Trust Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
Will Novavax ETFs Gain On Coronavirus Vaccine Progress?
Article By: Zacks Investment Research
Saturday, September 5, 2020 5:50 PM EDT
Novavax (NVAX) is a formidable name in the list of companies who are working on a vaccine. The company’s shares have gained 2487.4% this year. Let’s look at ETFs with the highest exposure to Novarax that can gain on the positive development,
In this article: BBH, PTH, IBB, DWAS, GERM
Read
Moderna ETFs To Gain On New Positive COVID-19 Vaccine Data
Article By: Zacks Investment Research
Friday, August 28, 2020 6:31 PM EDT
The competition to come up with a coronavirus vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.
In this article: IBB, BBH, XBI, MRNA, CNCR, BTEC, IDNA, GERM
Read
Biotech ETFs To Gain As Coronavirus Vaccine Hopes Strengthen
Article By: Zacks Investment Research
Sunday, July 5, 2020 1:58 PM EDT
The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to the biotech sector:
In this article: IBB, BBH, FBT, XBI, ARKG Also: AZN, JNJ, PFE, MRNA
Read
Moderna - A Step Closer To Coronavirus Vaccine: ETFs To Gain
Article By: Zacks Investment Research
Sunday, June 14, 2020 3:44 PM EDT
The first company to start human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has informed that it is on schedule to initiate the final-stage clinical trial by July.
In this article: AZN, JNJ, BBH, MRNA, CNCR, IDNA Also: IBB, XBI
Read
Race For Coronavirus Vaccine Heats Up: Biotech ETFs To Gain
Article By: Sweta Killa
Wednesday, May 27, 2020 11:34 AM EDT
Given rising spending on drugs and healthcare all over the world, investors should tap the opportune moment by investing in the biotech sector.
In this article: GNOM, IBB, BBH, XBI, BBC, ARKG Also: GSK, MRK, PFE, MRNA
Read

PARTNER HEADLINES

Latest Tweets for $BBH

No tweets yet!